C1QB

C1QB Full Name

complement component 1, q subcomponent, B chain

C1QB Introduction

Complement component 1, q subcomponent, B chain (C1QB), is a fundamental genetic blueprint that encodes the B-chain polypeptide of the C1q protein complex. C1q is a master recognition molecule of the innate immune system, famously known for initiating the classical complement pathway. Structurally, the mature C1q protein is a massive, tulip-like hexamer assembled from six A, six B, and six C chains. Physiologically, C1q acts as an essential immune sensor; its globular heads bind precisely to the Fc regions of IgG and IgM immune complexes, as well as to the surface markers of apoptotic (dying) cells. This binding activates a proteolytic cascade that ultimately leads to pathogen destruction, the safe clearance of immune complexes, and the prevention of autoimmunity. Beyond systemic immunity, the C1QB-encoded complex executes a critical, non-canonical function in the central nervous system (CNS), where it tags excess synaptic connections, mediating their pruning by microglia to refine neural circuits during brain development.

Figure 1. Structure of C1q. (Source: Kouser L, et al. 2015)

The clinical significance of C1QB is most starkly illustrated by its dysregulation, which drives vastly different pathologies depending on the tissue context. Genetic loss-of-function mutations specifically in the C1QB gene cause rare but severe congenital C1q deficiency. This immunodeficiency is almost universally penetrant for severe early-onset Systemic Lupus Erythematosus (SLE). Without functional C1q, the body loses its ability to safely and quietly clear apoptotic cell debris; consequently, these dying cells burst and release massive amounts of intracellular autoantigens, triggering a devastating autoimmune response. Conversely, the pathological upregulation of C1QB is deeply implicated in neurodegenerative disorders and oncology. In Alzheimer's disease, aberrantly high C1q levels inappropriately tag healthy synapses for destruction by microglia, driving rapid cognitive decline. Furthermore, in the tumor microenvironment, C1QB is highly expressed by tumor-associated macrophages (TAMs). Rather than attacking the cancer, this localized C1q production actively suppresses T-cell responses and promotes tumor angiogenesis and metastasis in malignancies like clear cell renal cell carcinoma. Thus, C1QB represents a delicate molecular balancing act: its deficiency triggers autoimmunity, while its overactivity fuels neurodegeneration and cancer progression.

Alternate Names for C1QB

C1QB; complement component 1, q subcomponent, B chain; complement component 1, q subcomponent, beta polypeptide; complement C1q subcomponent subunit B; Complement C1q subcomponent subunit B; Complement component 1 q subcomponent B chain; Complement compon

• 1. Kouser L, et al. Emerging and Novel Functions of Complement Protein C1q. Front Immunol. 2015 Jun 29;6:317.
  2. Sontheimer RD, et al. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol. 2005 Jul;125(1):14-23.